Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.
Because together, we are stronger.
Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities:
For general inquiries, email us at email@example.com.
To learn more about partnerships or working together, email us at firstname.lastname@example.org.
For investor and media inquiries, email us at email@example.com
830 Winter Street, Waltham, MA 02451